Healthcare Magazine September 2015 | Page 27

04 Juno
Therapeutics US $ 310 million
Privia Health US $ 414 million
MOST FUNDED STARTUPS

04 Juno

Therapeutics US $ 310 million

The biopharmaceutical company Juno Therapeutics , Inc . engages in developing cell-based cancer immunotherapies . Founded on the vision that the use of human T cells as therapeutics will drive one of the next important phases in medicine , the company develops its products based on its chimeric antigen receptor ( CAR ) and highaffinity T cell receptor ( TCR ) technologies . Juno Therapeutics has shown compelling evidence of tumor shrinkage in clinical trials using multiple cellbased product candidates to address refractory B-cell lymphomas and leukemias .

03

Privia Health US $ 414 million

Privia Health , LLC offers physician practice management and related services . It builds and enables high-performance physician groups and clinically integrated provider networks using technology , team-based care and wellness programs to help doctors manage the health of their populations . The company was founded in 2007 and is based in Arlington , Virginia .
27